Remdesivir + Remdesivir Placebo + Aviptadil + Aviptadil Placebo + Corticosteroid

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Covid19

Conditions

Covid19

Trial Timeline

Apr 20, 2021 → Nov 20, 2022

NCT ID

NCT04843761

About Remdesivir + Remdesivir Placebo + Aviptadil + Aviptadil Placebo + Corticosteroid

Remdesivir + Remdesivir Placebo + Aviptadil + Aviptadil Placebo + Corticosteroid is a phase 3 stage product being developed by Gilead Sciences for Covid19. The current trial status is completed. This product is registered under clinical trial identifier NCT04843761. Target conditions include Covid19.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04843761	Phase 3	Completed	Apr 20, 2021	Nov 20, 2022	Covid19

Competing Products

20 competing products in Covid19

See all competitors

Product	Company	Stage	Hype Score
Favipiravir + Nitazoxanide	Strides Pharma	Phase 2	51
Icosapent ethyl	Amarin Corporation	Approved	77
GX-03 + Petrolatum ointment	Turn Therapeutics	Phase 2	44
Cytotoxic T Lymphocytes	Tevogen Bio	Phase 1	25
DS-5670a + Placebo	Daiichi Sankyo	Phase 1/2	41
Pegylated Interferon-α2b	Zydus Lifesciences	Phase 2	52
Baricitinib	Eli Lilly	Phase 3	77
LY3819253 + Placebo + Remdesivir + VIR-7831 + BRII-196/BRII-198 + AZD7442 + MP0420 + PF-07304814	Eli Lilly	Phase 3	77
bamlanivimab	Eli Lilly	Approved	85
1x10^9 vp AZD1222 + 5x10^9 vp AZD1222 + 1x10^10 vp AZD1222	AstraZeneca	Phase 1	33
Sacubitril / Valsartan Oral Tablet [Entresto] + Placebo	Novartis	Phase 1/2	41
Pirfenidone	Roche	Pre-clinical	23
Remdesivir + Remdesivir Placebo + Corticosteroid	Gilead Sciences	Phase 3	76
Remdesivir	Gilead Sciences	Pre-clinical	22
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer)	Pfizer	Phase 3	76
Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine + CoronaVac COVID-19 vaccine + ChAdOx1 nCoV-19 Covid-19 Vaccine + Ad26.COV2.S COVID-19 Vaccine	Pfizer	Pre-clinical	22
Tofacitinib 10 mg + Placebo	Pfizer	Phase 3	76
BNT162b2	Pfizer	Phase 2	51
Anakinra + 0.9% Saline	Swedish Orphan Biovitrum	Phase 2	51
COVID-19 vaccine Pfizer (3 doses) + COVID-19 vaccine Pfizer (2 doses) + COVID-19 mRNA Vaccine Moderna (3 doses) + COVID-19 mRNA Vaccine Moderna (2 doses) + COVID-19 mRNA Vaccine Moderna (1 dose)	Sanofi	Approved	84

Other Products from Gilead Sciences

Ranolazine + PlaceboApproved

Truvada + Atazanavir + RitonavirApproved

Truvada + efavirenzApproved

B/F/TAF + Atripla + B/F/TAF Placebo + Atripla PlaceboApproved

TDF + Placebo Vaginal Gel + Vaginal TFV Gel + Placebo TabletsApproved